Eur Rev Med Pharmacol Sci 2018; 22 (4): 853-855
DOI: 10.26355/eurrev_201802_14357

Experimental study on the prevention of liver cancer angiogenesis via miR-126. Promising results for targeted therapy

S. Di Martino, C. Acierno, A. Licito

Scientific Directorate, CETAC Research Center, Caserta, Italy. salvo-dimartino@libero.it

Free PDF Download

To cite this article

S. Di Martino, C. Acierno, A. Licito
Experimental study on the prevention of liver cancer angiogenesis via miR-126. Promising results for targeted therapy

Eur Rev Med Pharmacol Sci
Year: 2018
Vol. 22 - N. 4
Pages: 853-855
DOI: 10.26355/eurrev_201802_14357

Keywords Related articles:

  1. Experimental study on the prevention of liver cancer angiogenesis via miR-126
  2. Clinical effects of bevacizumab targeted treatment on advanced colorectal cancer with liver metastasis
  3. From molecular imaging in preclinical/clinical oncology to theranostic applications in targeted tumor therapy
  4. Grouping of molecularly targeted anti-cancer agents based on cost-effectiveness analysis
  5. Can we decrease the acute proctitis in prostate cancer patients using hyaluronic acid during radiation therapy: a prospective historically controlled clinical study